Nabeela Ahmed Memon regulatory affairs pharmacist in the Kingdom of Bahrain with nearly a decade of progressive experience at the National Health Regulatory Authority (NHRA).

Currently serves as Head of Registration & Pricing and holds the additional responsibility of Chief of Pharmacy & Pharmaceutical Products Regulation department, leading national oversight of medicine registration, pricing, and regulatory compliance.

Leads national operations for pharmaceutical product registration and pricing, overseeing innovative, generic, and non-registered medicine portfolios in alignment with GCC and international standards.

Spearheaded the digital transformation of medicine registration through full implementation of the “Adweya” system, reducing review timelines by 35% and enhancing regulatory efficiency.

Deputy Chairperson of the Pharmaceutical Products Licensing Committee and represents Bahrain in regional GCC regulatory harmonization and GMP initiatives.

Recipient of the prestigious Prince Salman bin Hamad Medical Merit Award in recognition of her leadership and outstanding contribution during Bahrain’s national COVID-19 response.

Dr. Yasmine Hisham is a Regulatory Affairs professional and Manager of the Evaluation Unit of registration files for imported human pharmaceuticals within the Egyptian Drug Authority.

Dr. Yasmine has solid experience in the assessment of small molecule pharmaceuticals, with a focus on dossier evaluation, lifecycle management, and regulatory compliance. In her role, she contributes to enhancing review efficiency and supports regulatory initiatives aligned with international best practices.

Dr. Yasmine is particularly interested in regulatory harmonization and reliance approaches to improve timely access to safe and effective medicine.

Dr. Sboul is the Group Lead of Pharmaceutical Industry as part of the National Team responsible for developing Jordan’s Economic Modernization Vision 2023-2033, she is also a member of the Board of Jordan Food and Drug Administration JFDA, a member of Hashemite University Board of Trustees, the Vice Chair of the Steering Committee for the Jordan Pharmaceutical Center of Excellence, member of the Advisory Council of Pharmacy School at Jordan University of Science & Technology.

Dr. Sboul has also served as a Member of several Boards, including the Higher Education Council and The Higher Committee for Drugs & Pharmacy, the Scientific Research Support Fund, the Fund for Employment, Technical, Vocational Education & Training (E-TVET Fund), the University of Science & Technology Council, the Council of Pharmacy School at Jordan University.

At international level, Dr. Sboul was the Chair of the International Generic & Biosimilar Medicines Association IGBA in 2020. She was also a member of the USP Council of Convention, the Chair of the USP Convention Membership Committee & the Chair of USP MENA Regional Chapter. In her current and previous roles, Ms. Sboul is actively engaged in enhancing the regulatory landscape for pharmaceuticals to improve access to quality, safe & effective medicines and support local pharmaceutical industry.

Dr. Sboul received her MBA from Jordan University in 2000 and received her B.A in Pharmacy from Yarmouk University. She was the first Association Executive from Jordan to receive the Certified Association Executive Certificate from the American Society for Association Executives in 2005.

Dr. Mona Al Moussli is the Co-Founder and Managing Director of PRA Consultancy, with over 20 years of expertise in pharmaceutical and medical device regulatory affairs. She has led key initiatives like the GCC Regulatory Affairs Summit and the AfriSummit and developed the GCC Regulatory Affairs Course. Dr. Al Moussli also serves on several advisory boards, contributing to healthcare advancement and regulatory excellence in the region.

Dr. Rawya is a clinical pharmacist with broad Medical and Pharmaceutical knowledge, experience in various aspects of the Pharmaceutical Industry especially Medical Affairs, Regulatory Affairs and Pharmacovigilance, as well as knowledge and experience in the research field. She has a M.Sc. Clinical Pharmacy (with Distinction) – Queen’s University, UK.
Dr. Rawya began her career at Hikma Pharmaceuticals, Jordan since 1998 till 1999, and she is currently the Regulatory Affairs & Medical Affairs Director at Gulf Pharmaceutical Industries (Julphar), Ras Al Khaimah, United Arab Emirates since 2020 – to the present date.
In her role in Regulatory affairs, she displays and actions leadership in all aspects of Regulatory Affairs for company product portfolio of generics and novel products, including product development and submissions.
She is also an expert in defining the strategic regulatory direction for pipeline development and global launch excellence for a significant dedicated R&D budget. In addition, Dr. Rawya is knowledgeable of partnering with R&D and Global Strategic Marketing leaders as well another functional leader to develop and implement strategy for pipeline development and global launch excellence.

Dr. Diana Keilo is a highly accomplished pharmaceutical and regulatory affairs expert, recognized for her leadership at the intersection of healthcare, compliance, and digital innovation. With over 10 years of experience in the United Arab Emirates across pharmacy practice and healthcare operations, she brings deep expertise in regulatory frameworks, healthcare systems, and patient-centered pharmaceutical practices within complex and rapidly evolving environments.

Combining a strong scientific foundation with regulatory specialization, Dr. Diana holds a Bachelor’s degree in Pharmacy along with advanced diplomas in Regulatory Affairs, Clinical Research, and Quality Assurance. Her continued professional development in Canada has further strengthened her global perspective, where she is actively engaged as a healthcare educator, mentor, and consultant, supporting professionals and organizations in navigating regulatory requirements and evolving digital health strategies.

Dr. Diana is recognized for her ability to harmonize technological innovation with the core mission of healthcare. She actively contributes to advancing the integration of artificial intelligence and data-driven strategies in healthcare, supporting improved patient outcomes and driving forward pharmaceutical innovation.

Mr. Görkem is the Chief Marketing Officer at VISIOTT, specializing in Track and Trace solutions and Vision Inspection systems. With a fervent enthusiasm for data analytics and international trade, he thrives in fostering global partnerships and driving tangible results. He brings a wealth of experience to his role and is committed to pushing the boundaries of innovation in his field.

Dr. Samar Abdalhalim graduated with a bachelor’s degree in Pharmaceutical Sciences in 2007.

With over 18 years of dedicated experience in the pharmaceutical and personal healthcare industry, Samar Abdalhalim has had the privilege of making significant contributions to the regulatory field. She has been at the forefront of shaping the regulatory landscape and ensuring compliance within the P&G Health organization.

Dr. Samar has held various positions at leading companies such as Johnson & Johnson and, Procter & Gamble , where she honed her expertise in regulatory & medical affairs , research & development , product research and strategic planning.

Marc Chaillou is Head of Sales at Schlafender Hase. He has been working for the Pharmaceutical & Medical Devices industries for the last 13 years. Marc specialises in Regulatory Labelling and specifically how processes & technologies can reinforce, or compromise patient safety.